Save $100 on first order – Discount auto-applied at checkout

PubMed Central®Clinically Proven Weight Loss

PubMed Central®
Clinically Proven Weight Loss

Participants taking semaglutide lost an average of 14.9% of their body weight, confirming its clinical effectiveness for sustained weight loss.
American Diabetes AssociationAppetite and Craving Reduction

American Diabetes Association
Appetite and Craving Reduction

Semaglutide significantly reduced appetite, cravings, and preference for high-fat foods, supporting healthier eating behavior during treatment.
National Institutes of Health (NIH)Significant Individual Results

National Institutes of Health (NIH)
Significant Individual Results

33.8% of patients experienced over 15% body weight loss, showing the medication’s potential for transformative individual results.
Healthon

How it works

1Get started with a 3-minute medical questionnaire

Your answers will determine your qualification-100% online.

2Board-Certified Physician Medical Review

Personalized treatment protocol tailored to your goals.

3Expedited Medication Delivery

Your medication & supply shipped from a US-accredited pharmacy partner right to your doorstep

See if you qualify
* Medication will be shipped after the patient has been approved and deemed eligible for a prescription of compounded semaglutide, following the completion of the order processing.
Healthon

Doctor-Led Treatments
Grounded in Proven Science

“At Healthon, we’re not just managing weight—we’re transforming lives. By providing access to cutting-edge treatments like Tirzepatide, we empower individuals to achieve lasting health through science-backed, personalized care. Our focus is on improving metabolic health, not just addressing symptoms.”

Signature

Founder & CEO, Healthon

Dr. Rasoul M. Montazeri, MD | Triple Board-Certified Physician

Signature
Signature
  • Staff Role

    Justin Allen, MD

    Medical Director

  • Staff Role

    Thomas Bottoni, MD

    Lead Physician

  • Staff Role

    Christa Mckenzie, FNP

    Nurse Practitioner

Proven weight loss results

Proven weight loss results

Average results with Healthon:

14 pounds after 3 month

14.9% of body weight after a year

Proven weight loss results

We've created over 1000 success stories and we're just getting started

Get started
Verified Customer

“Real progress, finally.”

I’ve lost 22 pounds steadily, with better energy and blood sugar.

Verified Customer

“Nothing else worked like this.”

I lost 18 lbs in 3 months and finally feel in control of my hunger.

Verified Customer

“The confidence is back.”

For the first time in years, I feel hopeful, and it shows.

Verified Customer

“My cravings are totally gone.”

Semaglutide helped me eat less and choose better. Down 12% body weight.

Our Expert Team is Here to help with 24/7 support

How does Healthon’s Tirzepatide Plan work?
  1. Complete a Medical Intake Form: Upon registering, you will be asked to fill out a detailed medical intake form, which gathers your health history and relevant information about your goals.
  2. Review by a Physician: Once your intake form is submitted, one of Healthon’s licensed physicians will review your information to determine your medical eligibility for the program. Depending on your state’s telehealth regulations, this review will be conducted either through a SYNC (live) or ASYNC (offline) telehealth visit.
  3. Approval and Notification: If you are approved, you will receive a notification of your eligibility for the program, and your prescription for either Semaglutide or Tirzepatide will be issued.
  4. Medication Shipment: Once your prescription is approved, your medication will be shipped directly to your home. You will receive tracking information to monitor the delivery.
What medications are available through the Healthon’s GLP-1 treatment plan?

Healthon offers two highly effective GLP-1 medications:

  • Semaglutide (Generic Ozempic®/Wegovy®): A GLP-1 receptor agonist, FDA-approved for weight management and type 2 diabetes.
  • Tirzepatide (Generic Mounjaro®): A dual GLP-1 and GIP receptor agonist, FDA-approved for type 2 diabetes and used off-label for weight loss.

Both medications are administered via injection and work to promote weight loss by reducing appetite, enhancing feelings of fullness, and regulating blood sugar levels.

What’s the Difference Between Tirzepatide and Mounjaro®?

Tirzepatide is the active ingredient used in Mounjaro® pens. While both are used to manage type 2 diabetes and are increasingly prescribed off-label for weight management, there are key differences between the two.

  • Mounjaro® is the branded version of Tirzepatide, approved by the FDA and manufactured by Eli Lilly. It is typically more expensive and may require insurance or a prescription through a traditional healthcare provider.
  • Compounded Tirzepatide, like the version offered by Healthon, contains the same active ingredient but is prepared by licensed U.S. compounding pharmacies. It is often more affordable and accessible for individuals who may not qualify for, or have access to, brand-name prescription medications like Mounjaro® due to medical necessity.

Both work by activating GLP-1 and GIP receptors, helping regular blood sugar, suppress appetite, and support effective weight management.

Are There Any Side Effects Associated With Tirzepatide?

Most side effects are mild and tend to subside over time, but more serious side effects may occur in rare cases.

Common Side Effects:

  • Nausea: This is the most common side effect and usually occurs when starting the medication or after increasing the dose. It generally improves over time.
  • Vomiting
  • Diarrhea
  • Constipation
  • Indigestion
  • Decreased appetite

Less Common but Serious Side Effects:

  • Hypoglycemia (low blood sugar): Especially when used in combination with other diabetes medications like insulin.
  • Pancreatitis: In rare cases, GLP-1 medications have been associated with inflammation of the pancreas.
  • Gallbladder issues: Including gallstones.
  • Kidney problems: May lead to dehydration and worsen kidney function in patients with pre-existing kidney conditions.

Injection Site Reactions:

  • Redness or irritation at the injection site is possible but usually mild.

FDA Prescribing Information for Semaglutide (Ozempic)

FDA Prescribing Information for Tirzepatide (Mounjaro)

Trujillo, J. M., & Nuffer, W. (2020). GLP-1 receptor agonists for type 2 diabetes: Latest evidence and clinical considerations. Therapeutic Advances in Chronic Disease, 11, 2040622320968755.

Is insurance required?

No. Our program is self-pay and does not require insurance. This allows us to provide transparent pricing, direct access, and fewer barriers to care.

When will I receive my medication after approval?

Once you're approved, your first shipment is processed and sent within 1–2 business days. Most patients receive their medication in 3–5 days, depending on your location.

Am I guaranteed to be prescribed Tirzepatide if I sign up?

No. All prescriptions are based on medical eligibility. After you complete a health assessment, a licensed provider will review your information to determine if Tirzepatide is the right and safe choice for you. If you're not approved, you won’t be financially responsible.

What happens if I reach my goal weight?

Once you’ve reached your goal or your provider determines you’re ready to transition, we’ll support you in maintaining your results. This may include reducing your dose, switching to a maintenance plan, or discontinuing medication while continuing healthy lifestyle habits.

What’s included in my treatment plan—are doctor visits and medication covered?


Yes. Your treatment includes everything: your virtual consultation, provider review, prescription (if approved), ongoing support, and shipments of your Compounded Tirzepatide. There are no hidden fees.